BLAB — Britannia Life Sciences Cashflow Statement
0.000.00%
- CA$15.41m
- CA$11.10m
- CA$0.37m
- 74
- 68
- 39
- 64
Annual cashflow statement for Britannia Life Sciences, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2020 November 30th | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.2 | -14 | 5.84 | -4.4 | -4.56 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.18 | 16.1 | -4.45 | 5.34 | 0.81 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.75 | 0.461 | -0.415 | 0.885 | 1.07 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.207 | 2.8 | 1.22 | 2.09 | -2.62 |
| Capital Expenditures | 0 | -0.087 | -0.342 | -0.337 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.741 | -2.98 | -1.1 | 11.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0.654 | -3.32 | -1.44 | 11.3 |
| Financing Cash Flow Items | 1.93 | -0.596 | 0 | -1.8 | -1.79 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.022 | -2.58 | 2.95 | -1.97 | -2.17 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.185 | 0.803 | 0.967 | -1.28 | 6.53 |